Arizona Attorney General Kris Mayes on Thursday sued pharmaceutical manufacturer GlaxoSmithKline for engaging in deceptive and unfair practices ...

Arizona is suing a major drug maker, accusing it of gaming the system by simply renaming an asthma drug to increase its ...

Astex Pharmaceuticals has been celebrating a very successful first 25 years following a visit from Science minister Patrick ...

The bill, sponsored by Sen. John Kavanagh, would make it a misdemeanor if a minor "intentionally or knowingly" purchases or ...

Mitsubishi UFJ Morgan Stanley Securities and BofA Securities are serving as financial advisors, and Morrison Foerster, Mori, Hamada & Matsumoto and Ropes & Gray are serving as legal advisors to Bain ...

A battery manufacturing plant in Nairobi /FILEKenya’s unpredictable taxation coupled with regulatory burdens and the high cost and unreliable electricity have continued to dampen growth of industries, ...

Breakthrough research and investor enthusiasm prompted Cullinan Therapeutics to redirect one of its cancer programs toward ...

In a report released on February 5, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with ...

Arizona Attorney General Kris Mayes announced Thursday her office was suing a pharmaceutical company for alleged "deceptive" ...

The state’s top lawyer accused a British multinational drug company of “deceptive and unfair practices” that endangered lives and exploited American taxpayers.

GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...